Skip to content
Screener

Dianthus Therapeutics DNTH Net margin

Net margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
21.5%-3.5pp
Amgen logo
AmgenAMGN
23%+4.0pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-49.9%-22.6pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-4,987.4%-8,966pp
TG Therapeutics logo
TG TherapeuticsTGTX
55.2%+41.9pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-52,939.7%-61,871pp

Other financials

Income statement

See full
Revenue$396.0K-81.8%
Operating income-$46.5M-40.3%
Net income-$40.8M-38.4%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$627.7M+6,105%
Total debt$1.4M-2.3%
Total equity$1.2B+266%
Total assets$1.2B+258%

Cash flow

See full
Operating cash flow-$28.9M-4.4%
CapEx$10.0K-58.3%
Free cash flow-$28.9M-4.4%

Valuation

See full
Market cap$6.15B+838%
Enterprise value$5.52B+758%

Profitability

See full
Operating margin-4,558.4%-9,354pp
FCF margin-3,561.6%-6,956pp

Returns & leverage

See full
Return on equity-28.6%+3.2pp
Debt / equity0×0.0×
Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

net income/total revenue=-4,104.8%

Based on trailing twelve months.

The source filing: Dianthus Therapeutics’s 10-Q, filed November 5, 2025. Open the filing →

Filed
Nov 5, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001193125-25-266920

FAQ

What is Dianthus Therapeutics's net margin?
Dianthus Therapeutics (DNTH) reported net margin of -4,104.8% in Q3 2025.
How has Dianthus Therapeutics's net margin changed year-over-year?
Dianthus Therapeutics's net margin decreased by 228.3% year-over-year, from -1,250.3% to -4,104.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Dianthus Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude